Chemically Modified dNTPs as a General Approach to Improved Hot Start PCR
化学修饰 dNTP 作为改进热启动 PCR 的通用方法
基本信息
- 批准号:7481828
- 负责人:
- 金额:$ 38.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:2&apos-Deoxythymidine2&apos-deoxyadenosine2&apos-deoxycytidine 5&apos-triphosphateBiochemical ReactionBiomedical ResearchConditionDNADNA Microarray ChipDNA Microarray formatDNA SequenceDNA-Directed DNA PolymeraseDeoxycytidineDeoxyguanosineDevelopmentDiagnosticEnd PointEvaluationEvolutionFluoresceinFluoresceinsGoalsGovernmentGrantHandIn VitroInvestigationKnowledgeLabelLeadLigationMeasuresMicroarray AnalysisModificationMolecularNucleic AcidsNucleosidesNumbersOligonucleotide PrimersPerformancePersonsPhasePhase I Clinical TrialsPhase II Clinical TrialsPliabilityPolymerasePolymerase Chain ReactionPolymorphism AnalysisPreparationPreventionPrimer ExtensionProcessPropertyProtocols documentationPurposeRangeReactionReverse TranscriptionRouteSeriesShippingShipsSingle Nucleotide PolymorphismSmall Business Technology Transfer ResearchSolutionsSpecificityStructureSurfaceSystemTechniquesTechnologyTemperatureTherapeuticTimeTubeUniversitiesWorkanalogbasecold temperaturecostdeoxyguanosine triphosphatedesiredimerimprovedinterestnovelnovel strategiesnucleasenucleobasenucleobase analogresearch studysealthermostabilitythymidine 5&apos-triphosphatetripolyphosphate
项目摘要
DESCRIPTION (provided by applicant): The polymerase chain reaction (PCR) is a powerful technique used to amplify a DNA sequence of interest. Continual advancements to the technique have included development of real-time PCR technologies and reverse-transcription PCR. With the advent of these and other technologies that allow for accurate quantitation of a sequence of interest, there are continual needs for improvements to the accuracy of the technique. Herein we propose the further development of a novel Hot Start PCR strategy which may improve the specificity in PCR by reducing the number of undesired amplification products. Although numerous Hot Start PCR technologies have been developed, none of these utilize chemically-modified synthetic deoxynucleoside 5'- triphosphates (dNTPs). The present proposal aims to further develop modified dNTPs as a general solution for Hot Start activation in PCR. It is anticipated that this approach to Hot Start PCR should be amenable to existing PCR technologies, allowing for use with existing PCR systems, by simple substitution of the unmodified dNTP mix for the corresponding modified dNTP mix. In addition, we propose to further explore the utility of this technology in applications, such as single nucleotide polymorphism (SNP) detection and microarray analysis. Overall, we propose the development of a novel approach to Hot Start PCR that will offer an added level of specificity to nucleic acid amplification, with the flexibility for use in a number of PCR-based platforms.
描述(申请人提供):聚合酶链式反应(PCR)是一种用于扩增感兴趣的DNA序列的强大技术。该技术的不断进步包括实时聚合酶链式反应技术和逆转录聚合酶链式反应技术的发展。随着这些和其他允许对感兴趣序列进行准确定量的技术的出现,对该技术的精确度的改进存在持续的需求。在此,我们建议进一步发展一种新的热启动PCR策略,该策略可以通过减少不需要的扩增产物的数量来提高PCR的特异性。虽然已经开发了许多热启动聚合酶链式反应技术,但这些技术都没有利用化学修饰的合成脱氧核苷5‘-三磷酸(DNTPs)。本提案旨在进一步开发改良的dNTPs作为聚合酶链式反应中热启动激活的通用解决方案。预期这种热启动聚合酶链式反应的方法应该适用于现有的聚合酶链式反应技术,允许通过简单地用未修改的dNTP混合物替换相应的修改的dNTP混合物来与现有的聚合酶链式反应系统一起使用。此外,我们还建议进一步探索该技术在单核苷酸多态(SNP)检测和微阵列分析等应用中的应用。总体而言,我们建议开发一种新的热启动PCR方法,该方法将为核酸扩增提供更高水平的特异性,并具有在许多基于PCR的平台上使用的灵活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natasha Paul其他文献
Natasha Paul的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Natasha Paul', 18)}}的其他基金
Development of a Fully Enzymatic Oligonucleotide Synthesis Cycle by Engineered Template Independent Polymerases and a Novel Phosphate dNTP Blocking Group
通过工程模板独立聚合酶和新型磷酸 dNTP 封闭基团开发全酶促寡核苷酸合成循环
- 批准号:
10201535 - 财政年份:2021
- 资助金额:
$ 38.52万 - 项目类别:
Improved Library Preparation Workflows for Next Generation Sequencing
改进下一代测序的文库制备工作流程
- 批准号:
8455912 - 财政年份:2013
- 资助金额:
$ 38.52万 - 项目类别:
Chemical Determinants of DNA Ligase Fidelity
DNA 连接酶保真度的化学决定因素
- 批准号:
7804021 - 财政年份:2008
- 资助金额:
$ 38.52万 - 项目类别:
Chemical Determinants of DNA Ligase Fidelity
DNA 连接酶保真度的化学决定因素
- 批准号:
8012837 - 财政年份:2008
- 资助金额:
$ 38.52万 - 项目类别:
Chemical Determinants of DNA Ligase Fidelity
DNA 连接酶保真度的化学决定因素
- 批准号:
7537086 - 财政年份:2008
- 资助金额:
$ 38.52万 - 项目类别:
Chemically Modified dNTPs as a General Approach to Improved Hot Start PCR
化学修饰 dNTP 作为改进热启动 PCR 的通用方法
- 批准号:
7634464 - 财政年份:2007
- 资助金额:
$ 38.52万 - 项目类别:
相似海外基金
ACTG240--ZIDOVUDINE VS 2,3-DIDEHYDRO-3'DEOXYTHYMIDINE IN HIV+ CHILDREN
ACTG240--齐多夫定与 2,3-二氢-3脱氧胸苷治疗 HIV 儿童
- 批准号:
6247868 - 财政年份:1997
- 资助金额:
$ 38.52万 - 项目类别:
Synthesis of Deoxythymidine Momophosphate and Glutamyldeoxy Thymidylate By Phage
噬菌体合成脱氧胸苷单磷酸和谷氨酰脱氧胸苷酸
- 批准号:
7901803 - 财政年份:1979
- 资助金额:
$ 38.52万 - 项目类别:
Standard Grant
Regulation of Deoxythymidine Kinase in Mammalian Systems
哺乳动物系统中脱氧胸苷激酶的调节
- 批准号:
6928973 - 财政年份:1969
- 资助金额:
$ 38.52万 - 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
- 批准号:
3849039 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:
ZIDOVUDINE VS 2',3'DIDEHYDRO-3'DEOXYTHYMIDINE IN CHILDREN
齐多夫定与 2,3二氢-3脱氧胸苷在儿童中的比较
- 批准号:
3742272 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:
BMY-27857 (2'3'-DIDEHYDRO-3'-DEOXYTHYMIDINE, D4T) ADMINISTERED TO HIV+ PATIENTS
BMY-27857(23-二氢-3-脱氧胸苷,D4T)用于 HIV 患者
- 批准号:
3785276 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN W/HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
- 批准号:
5220423 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN W/HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
- 批准号:
2481037 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:
ZIDOVUDINE VS 2,3-DIDEHYDRO-3 DEOXYTHYMIDINE IN HIV+ CHILDREN
齐多夫定 VS 2,3-二氢-3 脱氧胸苷治疗 HIV 儿童
- 批准号:
3742165 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:
AZT VS 2',3' DIDEOHYDRO-3'DEOXYTHYMIDINE IN CHILDREN WITH HIV INFECTION
AZT 与 2,3 二脱氢-3脱氧胸苷治疗 HIV 感染儿童的比较
- 批准号:
3742543 - 财政年份:
- 资助金额:
$ 38.52万 - 项目类别:














{{item.name}}会员




